Ventas (NYSE:VTR) is a leading real estate investment trust (REIT) specializing in healthcare-related properties and seniors housing communities. The company’s diversified portfolio encompasses senior living facilities, medical office buildings, outpatient centers, life science research and innovation centers, and other properties that support the delivery of healthcare services. Through strategic acquisitions and development partnerships, Ventas aims to provide high-quality, purpose-built real estate solutions to healthcare operators and residents.
Founded in 1998 and headquartered in Chicago, Illinois, Ventas has grown its asset base through both organic development projects and targeted transactions. The company’s portfolio spans more than 1,200 properties across the United States, Canada, and the United Kingdom, reflecting its commitment to serving major healthcare markets. Ventas leverages long-term lease structures and active asset management to help operators enhance patient care and resident experiences while delivering stable, predictable cash flows.
Ventas collaborates with a broad network of healthcare providers, including leading seniors housing operators, hospital systems, academic research institutions, and life science companies. Its assets support a range of services, from independent and assisted living to skilled nursing, outpatient surgery, and cutting-edge biotech research. The company’s ability to tailor facility designs and lease arrangements to specific operator needs has underpinned its reputation for flexibility and operational excellence.
Under the leadership of President and Chief Executive Officer Debra A. Crew, Ventas continues to pursue a disciplined growth strategy that balances portfolio optimization with prudent capital allocation. The company’s board of directors and executive team emphasize sustainability, governance, and community engagement as core components of long-term value creation. With a focus on resilient healthcare real estate fundamentals, Ventas seeks to meet the evolving needs of an aging population and the expanding life science industry.
